Safety and Efficacy of Natalizumab in Japanese Patients with Relapsing-Remitting Multiple Sclerosis: Open-Label Extension Study of a Phase 2 Trial

por Saida, Takahiko, Kira, Jun-Ichi, Kishida, Shuji, Yamamura, Takashi, Ohtsuka, Nobuhisa, Ling, Yan, Torii, Shinichi, Lucas, Nisha, Kuesters, Geoffrey, Steiner, Deb, Tibung, J. T.
Publicado 2016

Cutaneous Adverse Events in the Randomized, Double-Blind, Active-Comparator DECIDE Study of Daclizumab High-Yield Process Versus Intramuscular Interferon Beta-1a in Relapsing-Remit...

por Krueger, James G., Kircik, Leon, Hougeir, Firas, Friedman, Adam, You, Xiaojun, Lucas, Nisha, Greenberg, Steven J., Sweetser, Marianne, Castro-Borrero, Wanda, McCroskery, Peter, Elkins, Jacob
Publicado 2016